The role of Treg cells and foxP3 expression in immunity of β-thalassemia major and β-thalassemia trait patients

Pediatric Hematology and Oncology

Volumn 27, Issue 7, 2010, Pages 534-545

  Bozdogan, Gunseli ^a   Erdem, Ela ^b   Demirel, Gulderen Yanikkaya ^c   Yildirmak, Yildiz ^b  

^a ACIBADEM HOSPITAL   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Centro Laboratuvarlari   (Turkey)

Author keywords

children; FoxP3; lymhocyte subsets; thalassemia; Treg cells

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CELL SURFACE MARKER; DEFERIPRONE; DEFEROXAMINE; FERRITIN; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CHELATION THERAPY; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE CONCENTRATE; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; HUMAN; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; SPLENECTOMY; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY; INFANT; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 77957226450     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.503334     Document Type: Article

References (30)

1. DeBaun MR, Vichinsky E. Hemoglobinopathies. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007: 2025-2038.
2. Arcasoy A, Cavdar AO. Thalassemia incidence in Turkey. In: M Aksoy, ed. Proceedings of the thalassemia symposium of medical research group. Ankara: Scientific and Technical Research Council of Turkiye; 1982:3-19.
3. Borgna-Pignatti C, Rugolotto S, De Stefeno P, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227-231. (Pubitemid 28369763)
4. Farmakis D, Giakomis A, Polymeropolus E, Aessopos A. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit. 2003;9:RA19-RA22. (Pubitemid 36206928)
5. Dwyer J, Wood C, McNamara J, et al. Abnormalities in the immune system of children with betathalassemia major. Clin Exp Immunol. 1987;68:621-629. (Pubitemid 17077149)
6. Khalifa AS, Maged Z, Khalil R, et al. T-cell function in infants and children with beta-thalassemia. Acta Haematol. 1988;79:153-156.
7. Ezer U, Gülderen F, Culha VK, et al. Immunological status of thalassemia syndrome. Pediatr Hematol Oncol. 2002;19:51-58. (Pubitemid 34665494)
8. Dua D, Choudhury M, Prakash K. Altered T and B lymphocytes in multitransfused patients of thalassemia major. Indian Pediatr. 1993;30:893-896.
9. Sinniah D, Yadav M. Elevated IgG and decreased complement C3 and factor B in β-thalassemia major. Acta Paediatr Scand. 1981;70:547-550. (Pubitemid 11078623)
10. Sen L, Goicoa MA, Nualart PJ, et al. Immunologic studies in thalassemia major. Medicina (Bueno Aires). 1989;49:131-134.
11. Walker EM Jr, Walker SM. Effects of iron overload on the immune system. Ann Clin Lab Sci. 2000;30:354-365.
12. Rohav G, Volach V, Shapiro M, et al. Severe infections in thalassaemic patients: prevelance and predisposing factors. Br J Haematol. 2006;133:667-674. (Pubitemid 43742785)
13. Consolini R, Calleri A, Legitimo A, Massei F. Immunological evaluation of patients with betathalassemia major. Acta Haematol. 2001;105:7-12. (Pubitemid 32424498)
14. Wonke B. Clinical management of beta-thalassemia major. Semin Hematol. 2001;38:350-359.
15. Wanachiwanawin W, SiripanyaphinyoU, Fucharoen S, et al. Activation of monocytes for the immune clearance of red cells in beta zero-thalassaemia/HbE. Br J Haematol. 1993;85:773-777. (Pubitemid 24003594)
16. Corthay A. How do regulator T cells work? Scand J Immunol. 2009;70:326-336.
17. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531-562. (Pubitemid 38680433)
18. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol. 2003;15:430-435. (Pubitemid 36774255)
19. Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest. 2004;9:1209-1217.
20. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061. (Pubitemid 36222930)
21. Lau KM, Cheng SH, Lo KW, et al. Increase in circulating Foxp3+CD4+CD25high regulatory T cells in nasopharyngeal carcinoma patients. Br J Cancer. 2007;96:617-622. (Pubitemid 46303530)
22. Musumeci S, Schiliro G, Romeo MA, et al. Lymphocyte changes in β-thalassaemia major. Arch Dis Child. 1979;54:954-957.
23. Pattanapanyasat K, Thepthai C, Lamchiagdhase P, et al. Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry. 2000;42:11-17. (Pubitemid 30131398)
24. Akbar AN, Giardina PJ, Hilgartner MW, Grady RW. Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positie cells. Clin Exp Immunol. 1985;62:397-404.
25. Del Vecchio GC, Schettini F, Piacente L, et al. Effects of deferiprone on immune status and cytokine pattern in thalassemia major. Acta Haematol. 2002;108:144-149. (Pubitemid 35316749)
26. Odeberg J, Soderberg-Naucler C. Reduced expression of HLA class II molecules and interleukin- 10 and transforming growth factor B1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures. J Virol. 2001;75:5174-5181. (Pubitemid 32448539)
27. Ikinciogullari A, Kendirli T, Dogu F, et al. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr. 2004;46:125-130. (Pubitemid 38735617)
28. Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the fork-head transcription factor foxp3. Immunity. 2005;22:329-341.
29. Kyriakou DS, Alexandrakis MG, Kyriakou E, et al. Activated peripheral blood and endothelial cells in thalasssemia patients. Ann Hematol. 2001;80:577-583. (Pubitemid 33061997)
30. Gharagozloo M, Karimi M, Amirghofran Z. Double-faced cell-mediated immunity in β-thalassemia major: stimulated phenotype versus suppressed activity. Ann Hematol. 2009;88:21-27.